IsoRay Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | IsoRay Inc.

IsoRay Inc. | Ownership

Companies that own IsoRay Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

1,489,944

2.21%

-15,134

06/30/2018

BlackRock Fund Advisors

869,606

1.29%

2,492

06/30/2018

Geode Capital Management LLC

269,778

0.4%

06/30/2018

Bridgeway Capital Management, Inc.

178,500

0.27%

06/30/2018

Northern Trust Investments, Inc.

124,577

0.19%

06/30/2018

The California Public Employees Retirement System

117,100

0.17%

06/30/2018

The Bank of New York Mellon Corp. (Investment Management)

67,416

0.1%

06/30/2018

Cahaba Wealth Management, Inc.

55,000

0.08%

0.01%

06/30/2018

Crestwood Advisors LLC

54,824

0.08%

06/30/2018

Virtu Financial BD LLC

32,111

0.05%

32,111

06/30/2018

About IsoRay

View Profile

Address	350 Hills Street Richland Washington 99354 United States
Employees	-
Website	http://www.isoray.com
Updated	07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.